In addition, IDH1 mutant gliomas exhibit an “immune-cold” microenvironment with abundant microglia, moderate myeloid cells, minimal B cells, and T cells, showing less immunoreaction than IDH wild-type (WT) counterparts (18, 19). The gene discussed is IDH2; the disease is central nervous system cancer.